DR
David Roman Goldman Sachs Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
SI
1
Shoulder Innovations, Inc.
SI
$304M
| $15.26 | $20 |
31%
upside
| Buy | 10 days ago |
|
2 |
CARL
2
Carlsmed, Inc. Common Stock
CARL
$344M
| $12.91 | $19 |
47%
upside
| Buy | 18 days ago |
|
3 |
OMDA
3
Omada Health, Inc. Common Stock
OMDA
$1.37B
| $23.72 | $29 |
22%
upside
| Buy | 2 months ago |
|
4 |
4
HealthEquity
HQY
$8.42B
| $97.70 | $104 |
6%
upside
| Neutral | 3 months ago |
|
5 |
BBNX
5
Beta Bionics, Inc. Common Stock
BBNX
$874M
| $20.10 | $16 |
20%
downside
| Neutral | 3 months ago |
|
6 |
6
Insulet
PODD
$24.4B
| $346.47 | $380 |
10%
upside
| Buy | 3 months ago |
|
7 |
7
Doximity
DOCS
$12.8B
| $68.52 | $50 |
27%
downside
| Neutral | 3 months ago |
|
8 |
8
Zimmer Biomet
ZBH
$20.8B
| $104.76 | $104 |
1%
downside
| Neutral | 4 months ago |
|
9 |
9
Teladoc Health
TDOC
$1.35B
| $7.63 | $10 |
31%
upside
| Buy | 4 months ago |
|
10 |
10
GE HealthCare
GEHC
$33.8B
| $74.12 | $82 |
11%
upside
| Buy | 4 months ago |
|
11 |
KMTS
11
Kestra Medical Technologies, Ltd. Common Stock
KMTS
$848M
| $16.51 | $23 |
39%
upside
| Neutral | 4 months ago |
|
12 |
12
Abbott
ABT
$231B
| $132.81 | $154 |
16%
upside
| Buy | 6 months ago |
|
13 |
13
Tandem Diabetes Care
TNDM
$837M
| $12.39 | $24 |
94%
upside
| Neutral | 6 months ago |
|
14 |
14
Solventum
SOLV
$12.5B
| $72.38 | $71 |
2%
downside
| Sell | 6 months ago |
|
15 |
15
LivaNova
LIVN
$3.18B
| $58.15 | $55 |
5%
downside
| Buy | 6 months ago |
|
16 |
16
Baxter International
BAX
$12.1B
| $23.58 | $42 |
78%
upside
| Buy | 6 months ago |
|
17 |
17
iRhythm Technologies
IRTC
$5.85B
| $182.17 | $124 |
32%
downside
| Neutral | 6 months ago |
|
18 |
18
Stryker
SYK
$151B
| $394.34 | $427 |
8%
upside
| Neutral | 7 months ago |
|
19 |
19
Edwards Lifesciences
EW
$47.5B
| $80.96 | $90 |
11%
upside
| Buy | 9 months ago |
|
20 |
20
Boston Scientific
BSX
$159B
| $107.29 | $90 |
16%
downside
| Buy | 1 year ago |
|
21 |
21
Intuitive Surgical
ISRG
$163B
| $454.52 | $500 |
10%
upside
| Buy | 1 year ago |
|
22 |
22
Becton Dickinson
BDX
$54.8B
| $191.26 | $274 |
43%
upside
| Buy | 1 year ago |
|
23 |
23
Medtronic
MDT
$119B
| $92.85 | $83 |
11%
downside
| Sell | 1 year ago |
|